Key Insights

Highlights

Treatment Research

2 treatments under study, led by Vasopressin Infusion When The Norepinephrine Dosage Is Equal To Or Greater Than 025 Mcgkgmin

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06471231Phase 4Unknown

Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock

Showing all 1 trials

Research Network

Common Treatments

  • Vasopressin Infusion When The Norepinephrine Dosage Is Equal To Or Greater Than 025 Mcgkgmin1
  • Vasopressin Infusion When The Norepinephrine Dosage Is Equal To Or Greater Than 05 Mcgkgmin1

Active Sponsors

  • Azienda Unita Sanitaria Locale Di Bologna1
  • Azienda Usl di Bologna1

Related Conditions

  • Septic Shock1

Activity Timeline